Dr. Adeel Khan

If your colto levels go too high, it can cause your PTH to go down, and it can kind of mess up your hormonal system, and there could actually be other detrimental side effects. So colto is definitely exciting, but I think we're still at least a year, a year and a half away after the clinical trial that we're starting now before we can start offering it to people.

If your colto levels go too high, it can cause your PTH to go down, and it can kind of mess up your hormonal system, and there could actually be other detrimental side effects. So colto is definitely exciting, but I think we're still at least a year, a year and a half away after the clinical trial that we're starting now before we can start offering it to people.

I'm going to be doing it on myself actually next month, so I'll keep you posted.

I'm going to be doing it on myself actually next month, so I'll keep you posted.

PTH, parathyroid hormone.

PTH, parathyroid hormone.

So you have to monitor it. So you have to do blood work for that. Yeah.

So you have to monitor it. So you have to do blood work for that. Yeah.

So It activates Wnt genes, which are these regenerative pathways. The Wnt gene pathway is kind of well known for being one of the more important ones that a lot of different regenerative molecules work on. And Clotho helps with that too. So it can facilitate regeneration and repair as well. And it can also, in terms of helping with neuronal death.

So It activates Wnt genes, which are these regenerative pathways. The Wnt gene pathway is kind of well known for being one of the more important ones that a lot of different regenerative molecules work on. And Clotho helps with that too. So it can facilitate regeneration and repair as well. And it can also, in terms of helping with neuronal death.

So there's something called the integrative stress response, which is what your neurons, when they are under stress, they have this stress response called ISR. And Clotho can help to mitigate that so there's less neuronal death. And that's why it can help with various... That's why there's so much interest for so many different neurodegenerative conditions.

So there's something called the integrative stress response, which is what your neurons, when they are under stress, they have this stress response called ISR. And Clotho can help to mitigate that so there's less neuronal death. And that's why it can help with various... That's why there's so much interest for so many different neurodegenerative conditions.

Yeah. So the costs will come down and then I believe in the net really like not, we're not talking like 10 years, we're talking within the next five years because we're very close to this kind of automation and of manufacturing. There's a company in, Silicon Valley that actually just started. And they're doing well. They basically figured out how to automate cell manufacturing using robotics.

Yeah. So the costs will come down and then I believe in the net really like not, we're not talking like 10 years, we're talking within the next five years because we're very close to this kind of automation and of manufacturing. There's a company in, Silicon Valley that actually just started. And they're doing well. They basically figured out how to automate cell manufacturing using robotics.

And so using that plus bioreactors, which allow you to grow a lot more cells a lot quicker, will significantly reduce the cost of manufacturing these cells. And obviously, if the cost of manufacturing goes down, then the cost of the consumer goes down.

And so using that plus bioreactors, which allow you to grow a lot more cells a lot quicker, will significantly reduce the cost of manufacturing these cells. And obviously, if the cost of manufacturing goes down, then the cost of the consumer goes down.

Yeah. And so that's, so that's, that's the first thing. And then the, the, the second thing is. there's economies of scale, which just means as more people do it and there's more demand, then obviously you can lower the pricing as, as there's going to be more people who are willing to do this type of treatment at a lower price point.

Yeah. And so that's, so that's, that's the first thing. And then the, the, the second thing is. there's economies of scale, which just means as more people do it and there's more demand, then obviously you can lower the pricing as, as there's going to be more people who are willing to do this type of treatment at a lower price point.

And that's one of the things, you know, I'm at, I'm very adamant about making this stuff accessible to the average person. And the only way that's going to happen, as you, as you just said, there has to be early adopters, right? You bought a Mac in 1988 and probably not many people had a Mac back then. So it's like, Uh, but there's going to be early adopters for every technology.

And that's one of the things, you know, I'm at, I'm very adamant about making this stuff accessible to the average person. And the only way that's going to happen, as you, as you just said, there has to be early adopters, right? You bought a Mac in 1988 and probably not many people had a Mac back then. So it's like, Uh, but there's going to be early adopters for every technology.